New approach for estimating risk of miscarriage after chorionic villus sampling

ABSTRACT Objective To estimate the risk of miscarriage associated with chorionic villus sampling (CVS). Methods This was a retrospective cohort study of women attending for routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation at one of eight fetal‐medicine units in Spain, Belgium...

Full description

Saved in:
Bibliographic Details
Published in:Ultrasound in obstetrics & gynecology 2020-11, Vol.56 (5), p.656-663
Main Authors: Gil, M. M., Molina, F. S., Rodríguez‐Fernández, M., Delgado, J. L., Carrillo, M. P., Jani, J., Plasencia, W., Stratieva, V., Maíz, N., Carretero, P., Lismonde, A., Chaveeva, P., Burgos, J., Santacruz, B., Zamora, J., De Paco Matallana, C.
Format: Article
Language:English
Subjects:
adverse pregnancy outcome
Algorithms
Amniocentesis
Aneuploidy
Anomalies
chorionic villus sampling
Fetuses
first‐trimester screening
Gestation
invasive procedures
invasive testing
Matching
Medical diagnosis
Miscarriage
Original Paper
Original Papers
Patients
Population studies
Pregnancy
pregnancy complications
Prenatal diagnosis
Randomization
Risk analysis
Risk factors
Sampling
Ultrasound
Villus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Objective To estimate the risk of miscarriage associated with chorionic villus sampling (CVS). Methods This was a retrospective cohort study of women attending for routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation at one of eight fetal‐medicine units in Spain, Belgium and Bulgaria, between July 2007 and June 2018. Two populations were included: (1) all singleton pregnancies undergoing first‐trimester assessment at Hospital Clínico Universitario Virgen de la Arrixaca in Murcia, Spain, that did not have CVS (non‐CVS group); and (2) all singleton pregnancies that underwent CVS following first‐trimester assessment at one of the eight participating centers (CVS group). We excluded pregnancies diagnosed with genetic anomalies or major fetal defects before or after birth, those that resulted in termination and those that underwent amniocentesis later in pregnancy. We used propensity score (PS) matching analysis to estimate the association between CVS and miscarriage. We compared the risk of miscarriage of the CVS and non‐CVS groups after PS matching (1:1 ratio). This procedure creates two comparable groups balancing the maternal and pregnancy characteristics that are associated with CVS, in a similar way to that in which randomization operates in a randomized clinical trial. Results The study population consisted of 22 250 pregnancies in the non‐CVS group and 3613 in the CVS group. The incidence of miscarriage in the CVS group (2.1%; 77/3613) was significantly higher than that in the non‐CVS group (0.9% (207/22 250); P 
ISSN:0960-7692
1469-0705
DOI:10.1002/uog.22041